Assessment of effectiveness of a COVID-adapted diagnostic pathway for colorectal cancer to mitigate the adverse impact on investigation and referrals (2020)
Attributed to:
Genetic approaches to combating colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.11.23.20236778
Publication URI: http://dx.doi.org/10.1101/2020.11.23.20236778
Type: Preprint